Alkermes plc Reports First Quarter 2022 Financial Results :

/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today reported financial results for the first quarter of 2022. "Our strong first quarter results reflect continued...

Related Keywords

Athlone , Westmeath , Ireland , Waltham , Massachusetts , United States , Ohio , Dublin , American , Katie Joyce , Iain Brown , Sandy Coombs , Alkermes , American Society Of Clinical Oncology , Schizophrenia International Research Society , Drug Administration , Baudax Bio Inc , Johnson Corporation , Biogen Inc , Nasdaq , Exchange Commission , Alkermes Inc , Alkermes Pharma Ireland , Society Of Gynecologic Oncology , First Quarter Revenues , Reflect Strong Performance , Financial Expectations , Richard Pops , Chief Executive Officer , Ended March , Goods Manufactured , Baudax Bio , Chief Financial Officer , American Society , Clinical Oncology , Gynecologic Oncology , Private Securities Litigation Reform Act , Annual Report , Alkermes Pharma Ireland Limited , Viiv Healthcare United Kingdom , Financial Information , Consolidated Statements , Months Ended , Earnings Per Share , Average Number , Ordinary Shares Outstanding , Quarterly Report ,